These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8927633)

  • 1. [Isoenzymes of the cytochrome P450 system: an accident or a physiologically significant concept?].
    Klotz U
    Pharm Unserer Zeit; 1996 Jul; 25(4):193-5. PubMed ID: 8927633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes].
    Filimonova AA; Ziganshin AU; Ziganshina LE
    Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytochrome P-450 isoenzymes as predictors of drug interactions].
    Pelkonen O
    Duodecim; 1994; 110(17):1575-9. PubMed ID: 7497987
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 6. The 1980 Bernard B. Brodie award lecture. Drug metabolism by cytochrome P-450: progress and perspectives.
    Coon MJ
    Drug Metab Dispos; 1981; 9(1):1-4. PubMed ID: 6111423
    [No Abstract]   [Full Text] [Related]  

  • 7. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity.
    Oesch-Bartlomowicz B; Oesch F
    Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 9. New techniques in drug metabolism and clinical pharmacology/pharmacokinetics.
    Benet LZ
    Am Biotechnol Lab; 1993 Feb; 11(2):44-7. PubMed ID: 7763426
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
    Lee JH; Oh JM; Lee MG
    Arch Pharm Res; 2008 Aug; 31(8):951-64. PubMed ID: 18787780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities.
    Dixit V; Hariparsad N; Desai P; Unadkat JD
    Biopharm Drug Dispos; 2007 Jul; 28(5):257-62. PubMed ID: 17443647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-associated disease: cytochrome P450 interactions.
    Mann HJ
    Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-dependent metabolism of arachidonic acid.
    Ivanov IV; Groza NV; Myagkova GI
    Biochemistry (Mosc); 1999 Jul; 64(7):725-37. PubMed ID: 10424895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.
    Crespi CL; Miller VP; Penman BW
    Anal Biochem; 1997 May; 248(1):188-90. PubMed ID: 9177742
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.